The effects of transdermal methylphenidate with reference to OROS methylphenidate in ADHD

被引：0
|
作者：
Lopez, Frank A. [1 ]
Shingler, Tarra [1 ]
Heinlein, Kristen [1 ]
机构：
[1] Childrens Dev Ctr, Maitland, FL USA
来源：
JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS | 2006年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：441 / 442
页数：2
相关论文
共 50 条
  • [21] Time Course of Treatment Effect of OROS® Methylphenidate in Children With ADHD
    Armstrong, Robert B.
    Damaraju, C. V.
    Ascher, Steve
    Schwarzman, Lesley
    O'Neill, James
    Starr, H. Lynn
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (08) : 697 - 705
  • [22] Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
    Hammerness, Paul
    Fried, Ronna
    Petty, Carter
    Meller, Benjamin
    Biederman, Joseph
    CHILD NEUROPSYCHOLOGY, 2014, 20 (03) : 319 - 327
  • [23] Effect of OROS methylphenidate on encopresis in children with ADHD: a retrospective chart review
    Yilmaz, Savas
    Bilgic, Ayhan
    Herguner, Sabri
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S216 - S216
  • [24] FDA approves methylphenidate transdermal system for the treatment of ADHD
    Naccari, C
    CNS SPECTRUMS, 2006, 11 (05) : 345 - 345
  • [25] Effectiveness and compatibility of OROS®-methylphenidate for adult with ADHS -: The long-acting methylphenidate in adult ADHD (LAMDA) trial
    Gerwe, Martin
    Philipsen, A.
    Roesler, M.
    Sobanski, E.
    Schaeuble, B.
    Medori, R.
    Trott, G. -E.
    NERVENARZT, 2007, 78 : 208 - 209
  • [26] Methylphenidate (OROS® formulation) -: A viewpoint
    Swanson, JM
    Lerner, M
    Steinhoff, K
    Wigal, S
    CNS DRUGS, 2001, 15 (06) : 502 - 503
  • [27] Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD
    Pelham, WE
    Burrows-MacLean, L
    Gnagy, EM
    Fabiano, GA
    Coles, EK
    Tresco, KE
    Chacko, A
    Wymbs, BT
    Wienke, AL
    Walker, KS
    Hoffman, MT
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2005, 13 (02) : 111 - 126
  • [28] The Impact of Age on Treatment Response With OROS® Methylphenidate (MPH) in Adults With ADHD
    Starr, Harriet L.
    Goodman, David W.
    Damaraju, Chandrasekhar Rao V.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 637 - 637
  • [29] Transitioning to OROS® methylphenidate from atomoxetine is effective in children and adolescents with ADHD
    Niederkirchner, Kaethe
    Slawik, Lara
    Wermelskirchen, Detlef
    Rettig, Klaus
    Schaeuble, Barbara
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2011, 11 (04) : 499 - 508
  • [30] Divergence by ADHD Subtype in Smoking Cessation Response to OROS-Methylphenidate
    Covey, Lirio S.
    Hu, Mei-Chen
    Weissman, Judith
    Croghan, Ivana
    Adler, Lenard
    Winhusen, Theresa
    NICOTINE & TOBACCO RESEARCH, 2011, 13 (10) : 1003 - 1008
12345